Clinical Trial Update: Attribution of Toxicities Due to Radiotherapy and Immuno-Biological Therapies

View source ↗

Summary

This is a clinical trial update focused on attributing toxicities to radiotherapy versus immuno-biological therapies, with the study currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Cancer, Radiotherapy Side Effect | Status: RECRUITING